H Matsushime

5.8k total citations · 4 hit papers
21 papers, 5.0k citations indexed

About

H Matsushime is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, H Matsushime has authored 21 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in H Matsushime's work include Cancer-related Molecular Pathways (7 papers), Virus-based gene therapy research (4 papers) and Ubiquitin and proteasome pathways (3 papers). H Matsushime is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Virus-based gene therapy research (4 papers) and Ubiquitin and proteasome pathways (3 papers). H Matsushime collaborates with scholars based in United States, Japan and Hungary. H Matsushime's co-authors include C J Sherr, Jun‐ya Kato, Martine F. Roussel, Richard A. Ashmun, Charles J. Sherr, Mark E. Ewen, Scott W. Hiebert, Masatoshi Shibuya, Dawn E. Quelle and Sheila Shurtleff and has published in prestigious journals such as Cell, The Journal of Experimental Medicine and Genes & Development.

In The Last Decade

H Matsushime

21 papers receiving 4.9k citations

Hit Papers

Direct binding of cyclin ... 1990 2026 2002 2014 1993 1991 1994 1990 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Matsushime United States 16 3.4k 2.7k 844 653 556 21 5.0k
C J Sherr United States 18 4.3k 1.3× 3.9k 1.4× 986 1.2× 687 1.1× 499 0.9× 19 6.0k
Eduardo Firpo United States 16 3.1k 0.9× 2.7k 1.0× 671 0.8× 573 0.9× 485 0.9× 21 4.5k
Jiří Lukáš Denmark 31 4.0k 1.2× 3.7k 1.4× 928 1.1× 899 1.4× 325 0.6× 53 6.0k
Martin van der Valk Netherlands 33 4.0k 1.2× 3.6k 1.3× 570 0.7× 703 1.1× 570 1.0× 45 6.9k
Dalia Resnitzky Israel 18 2.7k 0.8× 2.3k 0.8× 753 0.9× 410 0.6× 604 1.1× 21 3.8k
Dawn E. Quelle United States 30 4.5k 1.3× 3.7k 1.4× 896 1.1× 725 1.1× 535 1.0× 70 6.5k
Lee Ann Remington United States 13 3.5k 1.0× 3.5k 1.3× 483 0.6× 981 1.5× 398 0.7× 15 5.8k
Takehiko Kamijo Japan 37 5.1k 1.5× 3.2k 1.2× 574 0.7× 1.0k 1.6× 670 1.2× 114 7.1k
Hiroaki Kiyokawa United States 47 5.5k 1.6× 3.5k 1.3× 1.2k 1.4× 958 1.5× 493 0.9× 117 7.8k
Earlene M. Schmitt United States 10 5.0k 1.5× 4.0k 1.5× 691 0.8× 1.1k 1.7× 618 1.1× 13 7.5k

Countries citing papers authored by H Matsushime

Since Specialization
Citations

This map shows the geographic impact of H Matsushime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Matsushime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Matsushime more than expected).

Fields of papers citing papers by H Matsushime

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Matsushime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Matsushime. The network helps show where H Matsushime may publish in the future.

Co-authorship network of co-authors of H Matsushime

This figure shows the co-authorship network connecting the top 25 collaborators of H Matsushime. A scholar is included among the top collaborators of H Matsushime based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Matsushime. H Matsushime is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inamura, Kohei, Shinobu Mochizuki, Hiromichi Yokoi, et al.. (2003). Response to ADP-Ribose by Activation of TRPM2 in the CRI-G1 Insulinoma Cell Line. The Journal of Membrane Biology. 191(3). 201–207. 82 indexed citations
2.
Takasaki, Jun, Masazumi Kamohara, Tsugumichi Saito, et al.. (2001). Molecular Cloning of the Platelet P2TAC ADP Receptor: Pharmacological Comparison with Another ADP Receptor, the P2Y1 Receptor. Molecular Pharmacology. 60(3). 432–439. 119 indexed citations
3.
Nakanishi, M., et al.. (1997). Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.. PubMed. 11 Suppl 3. 356–7. 2 indexed citations
4.
Kato, Akihiko, Hidekazu Takahashi, Yusuke Takahashi, & H Matsushime. (1997). Contact inhibition-induced inactivation of the cyclin D-dependent kinase in rat fibroblast cell line, 3Y1.. PubMed. 11 Suppl 3. 361–2. 7 indexed citations
5.
Suzuki, Tadashi, Saori Kitao, H Matsushime, & Minoru Yoshida. (1996). HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.. The EMBO Journal. 15(7). 1607–1614. 228 indexed citations
6.
Miyatake, Shoichiro, Hiroyasu Nakano, Tetsuo Yamazaki, et al.. (1995). Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas.. The Journal of Experimental Medicine. 182(2). 401–408. 30 indexed citations
7.
Matsushime, H. (1995). [Macrophage cell cycle control by M-CSF/CSF-1].. PubMed. 36(5). 406–9. 1 indexed citations
8.
Matsushime, H, Dawn E. Quelle, Sheila Shurtleff, et al.. (1994). D-type cyclin-dependent kinase activity in mammalian cells.. Molecular and Cellular Biology. 14(3). 2066–2076. 965 indexed citations breakdown →
9.
Shibuya, Masabumi, et al.. (1994). Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.. PubMed. 24. 162–70. 17 indexed citations
10.
Kato, Jun‐ya, H Matsushime, Scott W. Hiebert, Mark E. Ewen, & C J Sherr. (1993). Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes & Development. 7(3). 331–342. 1065 indexed citations breakdown →
11.
Matsushime, H, et al.. (1993). Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.. PubMed. 53(22). 5535–41. 307 indexed citations
12.
Matsushime, H, Martine F. Roussel, & Charles J. Sherr. (1991). Novel Mammalian Cyclins (CYL Genes) Expressed during G1. Cold Spring Harbor Symposia on Quantitative Biology. 56(0). 69–74. 61 indexed citations
13.
Matsushime, H, Martine F. Roussel, Richard A. Ashmun, & C J Sherr. (1991). Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 65(4). 701–713. 1033 indexed citations breakdown →
14.
15.
16.
Shibuya, M., Sachiko Yamaguchi, Arito Yamane, et al.. (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.. PubMed. 5(4). 519–24. 809 indexed citations breakdown →
17.
Matsushime, H, Atsushi Jinno, Nobuo Takagi, & Masaaki Shibuya. (1990). A novel mammalian protein kinase gene (mak) is highly expressed in testicular germ cells at and after meiosis.. Molecular and Cellular Biology. 10(5). 2261–2268. 106 indexed citations
18.
Matsushime, H & Masaaki Shibuya. (1990). Tissue-specific expression of rat c-ros-1 gene and partial structural similarity of its predicted products with sev protein of Drosophila melanogaster. Journal of Virology. 64(5). 2117–2125. 38 indexed citations
19.
Satoh, H., Michihiro C. Yoshida, H Matsushime, Masaaki Shibuya, & Motomichi Sasaki. (1987). Regional localization of the human c-ros-1 on 6q22 and flt on 13q12.. PubMed. 78(8). 772–5. 27 indexed citations
20.
Shibuya, Masabumi, H Matsushime, Hideya Yamazaki, et al.. (1986). Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.. PubMed. 17. 195–202. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026